scholarly journals Bile Acid Transporters Are Expressed and Heterogeneously Distributed in Rat Bile Ducts

Gut and Liver ◽  
2019 ◽  
Vol 13 (5) ◽  
pp. 569-575 ◽  
Author(s):  
Zhu-lin Luo ◽  
Long Cheng ◽  
Tao Wang ◽  
Li-jun Tang ◽  
Fu-zhou Tian ◽  
...  
2001 ◽  
Vol 121 (1) ◽  
pp. 140-147 ◽  
Author(s):  
Lee A. Denson ◽  
Ekkehard Sturm ◽  
Wihelma Echevarria ◽  
Tracy L. Zimmerman ◽  
Makoto Makishima ◽  
...  

2021 ◽  
Vol 120 (3) ◽  
pp. 303a-304a
Author(s):  
Azaan Wilbon ◽  
Jiemin Shen ◽  
Pei Qiao ◽  
Zachary J. Knepp ◽  
Wonpil Im ◽  
...  

1971 ◽  
Vol 138 (2) ◽  
pp. 645-650 ◽  
Author(s):  
W. T. Beher ◽  
K. K. Casazza ◽  
G. J. Lin

1992 ◽  
Vol 262 (2) ◽  
pp. G351-G358
Author(s):  
R. Zhang ◽  
S. Barnes ◽  
R. B. Diasio

Mechanisms responsible for the difference in the relative amounts of taurine- and glycine-conjugated bile acid N-acyl amidates (Tau/Gly ratio) are not fully understood. In the present study, the stability of taurine- and glycine-conjugated bile acid N-acyl amidates during intestinal transit and absorption was examined to investigate the contribution of intestinal deconjugation to the Tau/Gly ratio in rat bile. Radiolabeled chenodeoxycholic acid (CDC) and its N-acyl amidates with glycine (CDC-Gly) or taurine (CDC-Tau) were introduced into the lumen of the upper small intestine in the biliary fistula rats, and radioactive metabolites in bile, blood, urine, and tissues were identified and quantitated by high-performance liquid chromatography. Results indicated that 1) extensive deconjugation of CDC-Gly occurs during intestinal absorption; 2) CDC-Tau is recovered in bile largely intact; and 3) newly synthesized CDC-Tau and CDC-Gly are formed in a ratio of less than 2:1 after administration of [14C]-CDC. In summary, the present study demonstrates that resistance of taurine-conjugated bile acid N-acyl amidates to hydrolysis in the intestine, rather than a difference in synthesis of taurine- and glycine-conjugated N-acyl amidates in liver, may account for the high Tau/Gly ratio in rat bile.


2018 ◽  
Vol 2018 ◽  
pp. 1-9 ◽  
Author(s):  
Stef De Lombaerde ◽  
Ken Kersemans ◽  
Sara Neyt ◽  
Jeroen Verhoeven ◽  
Christian Vanhove ◽  
...  

Introduction. An in vivo determination of bile acid hepatobiliary transport efficiency can be of use in liver disease and preclinical drug development. Given the increased interest in bile acid Positron Emission Tomography- (PET-) imaging, a further understanding of the impact of 18-fluorine substitution on bile acid handling in vitro and in vivo can be of significance. Methods. A number of bile acid analogues were conceived for nucleophilic substitution with [18F]fluoride: cholic acid analogues of which the 3-, 7-, or 12-OH function is substituted with a fluorine atom (3α-[18F]FCA; 7β-[18F]FCA; 12β-[18F]FCA); a glycocholic and chenodeoxycholic acid analogue, substituted on the 3-position (3β-[18F]FGCA and 3β-[18F]FCDCA, resp.). Uptake by the bile acid transporters NTCP and OATP1B1 was evaluated with competition assays in transfected CHO and HEK cell lines and efflux by BSEP in membrane vesicles. PET-scans with the tracers were performed in wild-type mice (n=3 per group): hepatobiliary transport was monitored and compared to a reference tracer, namely, 3β-[18F]FCA. Results. Compounds 3α-[18F]FCA, 3β-[18F]FGCA, and 3β-[18F]FCDCA were synthesized in moderate radiochemical yields (4–10% n.d.c.) and high radiochemical purity (>99%); 7β-[18F]FCA and 12β-[18F]FCA could not be synthesized and included further in this study. In vitro evaluation showed that 3α-FCA, 3β-FGCA, and 3β-FCDCA all had a low micromolar Ki-value for NTCP, OATP1B1, and BSEP. In vivo, 3α-[18F]FCA, 3β-[18F]FGCA, and 3β-[18F]FCDCA displayed hepatobiliary transport with varying efficiency. A slight yet significant difference in uptake and efflux rate was noticed between the 3α-[18F]FCA and 3β-[18F]FCA epimers. Conjugation of 3β-[18F]FCA with glycine had no significant effect in vivo. Compound 3β-[18F]FCDCA showed a significantly slower hepatic uptake and efflux towards gallbladder and intestines. Conclusion. A set of 18F labeled bile acids was synthesized that are substrates of the bile acid transporters in vitro and in vivo and can serve as PET-biomarkers for hepatobiliary transport of bile acids.


Hepatology ◽  
2007 ◽  
Vol 2 (4) ◽  
pp. 433S-439S ◽  
Author(s):  
David E. Hatoff ◽  
William G. M. Hardison

2002 ◽  
Vol 66 (2) ◽  
pp. 467-470 ◽  
Author(s):  
Tohru SAEKI ◽  
Toshinori KURODA ◽  
Makiko MATSUMOTO ◽  
Ryuhei KANAMOTO ◽  
Kimikazu IWAMI

2005 ◽  
Vol 15 (1) ◽  
pp. 85-87 ◽  
Author(s):  
Laxminarayan Bhat ◽  
Bernd Jandeleit ◽  
Tracy M. Dias ◽  
Tristen L. Moors ◽  
Mark A. Gallop

Sign in / Sign up

Export Citation Format

Share Document